NCT07011992View on ClinicalTrials.gov

A Study to Assess the Effects of BPN14770 on Rosuvastatin

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 18, 2025

Primary Completion Date

July 31, 2025

Study Completion Date

August 7, 2025

Conditions
Healthy Participants
Interventions
DRUG

Rosuvastatin

Oral tablet

DRUG

BPN14770

Oral capsule

Trial Locations (1)

66219

ICON Clinical Research, Lenexa

Sponsors

Lead Sponsor

Shionogi
All Listed Sponsors
lead

Shionogi

INDUSTRY